Showing results (1781-1790 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|December 20, 2019
Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil, and Leucovorin Versus Oxaliplatin, 5-Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG-ACRIN Research Group (E5204)A Bapsi Chakravarthy, Fengmin Zhao, Neal J Meropol, et al.
The Oncologist|February 14, 2019
High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive ChemoradiotherapyDevarati Mitra, Nora K Horick, Diane G Brackett, et al.
The Oncologist|February 16, 2018
Pantoprazole, an Inhibitor of the Organic Cation Transporter 2, Does Not Ameliorate Cisplatin-Related Ototoxicity or Nephrotoxicity in Children and Adolescents with Newly Diagnosed Osteosarcoma Treated with Methotrexate, Doxorubicin, and CisplatinElizabeth Fox, Kristin Levin, Yan Zhu, et al.
The Oncologist|July 7, 2016
Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Is It a Valid Treatment Option?Patrizia Mondello, Normann Steiner, Wolfgang Willenbacher, et al.
The Oncologist|July 7, 2016
Outcome of Patients With Metastatic Chromophobe Renal Cell Carcinoma Treated With SunitinibDaniel Keizman, David Sarid, Jae L Lee, et al.
The Oncologist|July 16, 2017
Vincristine, Ifosfamide, and Doxorubicin for Initial Treatment of Ewing Sarcoma in AdultsMichael J Wagner, Vancheswaran Gopalakrishnan, Vinod Ravi, et al.
The Oncologist|July 3, 2016
Palbociclib in Combination With Fulvestrant in Women With Hormone Receptor-Positive/HER2-Negative Advanced Metastatic Breast Cancer: Detailed Safety Analysis From a Multicenter, Randomized, Placebo-Controlled, Phase III Study (PALOMA-3)Sunil Verma, Cynthia Huang Bartlett, Patrick Schnell, et al.
The Oncologist|July 3, 2016
An Introduction to a Head and Neck Cancer-Specific Frailty Index and Its Clinical Implications in Elderly Patients: A Prospective Observational Study Focusing on Respiratory and Swallowing FunctionsMinsu Kwon, Shin-Ae Kim, Jong-Lyel Roh, et al.
The Oncologist|July 15, 2017
Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and RecommendationsLaura M Spring, Mark L Zangardi, Beverly Moy, et al.
The Oncologist|November 9, 2001
Targeting hypomethylation of DNA to achieve cellular differentiation in myelodysplastic syndromes (MDS)L R Silverman
Pageof 571